Icu Medical Inc/De
—- Market cap
- $4.19B
- Debt
- +$1.28B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 77% equity / 23% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: ICUI stock price at premium vs EMN $167.58 current versus $0.52 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EMN's multiple
Implied fair value · at ICUI's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ICUI FY 2025 (ended Dec 31, 2025) · EMN FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 77% equity / 23% debt
Capital structure 63% equity / 37% debt · EV / Revenue 1.41x · EV / EBITDA 9.61x
EMN carries the larger enterprise value at $12.36B against $5.48B; EMN trades on the lower EV / Revenue multiple (1.41x vs 2.45x); EMN on the lower EV / EBITDA (9.61x vs 13.54x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ICU MEDICAL INC/DE · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
EASTMAN CHEMICAL CO · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.60x
0.80x
Net debt / EBITDA
Leverage against operating earnings
—
3.28x
Cash and equivalents
Liquid reserves on the balance sheet
—
$566.00M
Total debt
Interest-bearing obligations outstanding
$1.28B
$4.79B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BECTON DICKINSON & CO
ICUI vs BDX
TELEFLEX INC
ICUI vs TFX
HAEMONETICS CORP
ICUI vs HAE
BAXTER INTERNATIONAL INC
ICUI vs BAX
Celanese Corp
ICUI vs CE
DuPont de Nemours, Inc.
ICUI vs DD
ALBEMARLE CORP
ICUI vs ALB
LyondellBasell Industries N.V.
ICUI vs LYB
ECOLAB INC.
ICUI vs ECL
PPG INDUSTRIES INC
ICUI vs PPG
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.